Experimental Oncology
Indicator:
| Year |
P |
IPP |
SNIP |
% self cit |
| 1999 |
169 |
0.09 |
0.10 |
53.3% |
| 2000 |
148 |
0.05 |
0.05 |
75.0% |
| 2001 |
138 |
0.15 |
0.14 |
47.6% |
| 2002 |
157 |
0.13 |
0.11 |
71.4% |
| 2003 |
168 |
0.22 |
0.16 |
48.6% |
| 2004 |
185 |
0.17 |
0.14 |
81.3% |
| 2005 |
188 |
0.66 |
0.27 |
50.0% |
| 2006 |
187 |
0.80 |
0.42 |
28.2% |
| 2007 |
185 |
1.12 |
0.58 |
14.4% |
| 2008 |
182 |
0.91 |
0.34 |
10.9% |
| 2009 |
174 |
1.06 |
0.44 |
5.4% |
| 2010 |
158 |
1.17 |
0.45 |
8.1% |
| 2011 |
153 |
1.46 |
0.59 |
5.8% |
| 2012 |
148 |
1.64 |
0.70 |
3.3% |
| 2013 |
167 |
1.67 |
0.57 |
3.6% |
| 2014 |
167 |
2.07 |
0.77 |
5.2% |
| 2015 |
170 |
2.25 |
0.88 |
4.2% |
| 2016 |
160 |
1.03 |
0.39 |
12.1% |
| 2017 |
157 |
0.99 |
0.38 |
9.0% |
| 2018 |
157 |
1.02 |
0.47 |
15.6% |
| 2019 |
157 |
0.90 |
0.36 |
11.3% |
| 2020 |
163 |
1.10 |
0.36 |
15.0% |
| 2021 |
170 |
1.10 |
0.34 |
9.6% |
| 2022 |
183 |
0.92 |
0.28 |
10.1% |
| 2023 |
182 |
0.79 |
0.32 |
17.4% |
| 2024 |
178 |
0.77 |
0.23 |
17.5% |